amikacin vs cefdinir
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of amikacin and cefdinir. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Amikacin is an antibiotic medicine. It fights serious infections caused by certain types of bacteria.
Cefdinir is an antibiotic that fights bacteria in your body. It is used to treat different types of infections.
Amikacin treats serious infections caused by bacteria. This includes infections in the blood, lungs, bones, joints, brain, skin, and abdomen. It can also treat burns, post-surgery infections, and complicated urinary tract infections.
Cefdinir treats mild to moderate infections caused by certain bacteria. It can treat pneumonia, bronchitis, and sinus infections. It is also used for strep throat and skin infections.
Amikacin belongs to a class of drugs called aminoglycosides. It works by stopping the growth of bacteria. This helps your body fight off the infection.
Cefdinir belongs to a class of drugs called cephalosporins. It works by stopping the growth of bacteria. This helps your body fight off the infection.
No common side effects listed.
- • Diarrhea
- • Vaginal yeast infection (in women)
- • Nausea
- • Headache
- Cough 1,620
- Dyspnoea 1,556
- Hospitalisation 1,360
- Therapy Interrupted 1,348
- Death 1,103
- Diarrhoea 508
- Chronic Kidney Disease 485
- Pneumonia 466
- Fatigue 442
- Nausea 382
Amikacin can potentially cause hearing loss and kidney damage. Tell your doctor if you have kidney problems or are taking other medicines that can affect your hearing or kidneys. Your doctor should closely monitor you for hearing and kidney problems during treatment. This drug can also cause muscle weakness or breathing problems, especially if you are also taking anesthesia or certain muscle relaxants.
You should not take this medicine if you are allergic to cephalosporin antibiotics.
Tell your doctor if you are pregnant or breastfeeding. Amikacin may harm your unborn baby. It is not known if amikacin passes into breast milk.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if cefdinir will harm an unborn baby. Talk to your doctor about the risks and benefits of taking cefdinir while breastfeeding.
Also Compare, Nearby Drugs
Compare amikacin with
Compare cefdinir with
How to Read This amikacin vs cefdinir Comparison
amikacin is classified in the Aminoglycoside Antibiotic drug class, while cefdinir sits within the Third-Generation Cephalosporin class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, amikacin has 6,987 submissions while cefdinir has 2,283. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for amikacin or cefdinir.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.